Market Place
Sourcing Support
Actineer Begins Production Of Actinium-225 Joint Venture
18 Oct 2024 //
BUSINESSWIRE
TerraPower Isotopes Brings Actinium-225 to Market
01 Oct 2024 //
BUSINESSWIRE
BWXT And NorthStar Sign Supply Deal For Actinium-225 Production
22 Jul 2024 //
BUSINESSWIRE
IONETIX Produces First Batch of Actinium-225
07 Jun 2024 //
PR NEWSWIRE
BWXT Submits Actinium-225 API Drug Master File To FDA
07 Jun 2024 //
BUSINESSWIRE
NorthStar Medical Radioisotopes and Alpha-9 Oncology Enter Strategic Agreement
08 Jan 2024 //
BUSINESSWIRE
RayzeBio Completes Phase 1b Enrollment in ACTION-1 Study, Evaluating RYZ101
20 Mar 2023 //
BUSINESSWIRE
RayzeBio Advances RYZ101, into Clinical Development for Two Cancer Indications
13 Sep 2022 //
BUSINESSWIRE
Aktis Oncology Announces Actinium-225 Supply Agreements with Isotope Producers
23 Aug 2022 //
PRNEWSWIRE
Nihon Medi-Physics Attains World`s First Mfg of Actinium-225 with Cyclotron
05 Apr 2022 //
PRNEWSWIRE
Fusion Pharma to Present Preclinical Data Supporting FPI-1966 & FPI-2059
20 Oct 2021 //
PRNEWSWIRE
BWXT Medical & Bayer Sign Agreement for Development & Production of Actinium-225
16 Sep 2021 //
BUSINESSWIRE
TerraPower and Cardinal Health announce agreement for Actinium-225
12 Aug 2021 //
WEBWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.